Hofheim, Germany

Stefanie Keil

USPTO Granted Patents = 42 

 

Average Co-Inventor Count = 7.0

ph-index = 6

Forward Citations = 122(Granted Patents)


Location History:

  • Franfurt am Main, DE (2011)
  • Hofheim, DE (2003 - 2012)
  • Frankfurt-am-Main, DE (2009 - 2015)

Company Filing History:


Years Active: 2003-2015

Loading Chart...
Loading Chart...
42 patents (USPTO):

Title: **Stefanie Keil: A Pioneer in Pharmaceutical Innovations**

Introduction

Stefanie Keil is a renowned inventor based in Hofheim, Germany, recognized for her significant contributions to the field of pharmaceuticals with a remarkable portfolio of 42 patents. Her work primarily focuses on innovative compounds that hold promise for treating various metabolic and neurodegenerative disorders.

Latest Patents

Two of her latest inventions have garnered attention within the pharmaceutical community. The first is titled "Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals." This patent discusses compounds featuring an oxadiazolone headgroup and their ability to act as PPARdelta or PPARdelta and PPARalpha agonists. These compounds are particularly useful in treating disorders related to fatty acid metabolism, glucose utilization, and insulin resistance, along with addressing various neurodegenerative disorders.

The second innovative patent addresses "Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament." This invention revolves around the development of spirocyclic compounds and their physiologically compatible salts, focusing on their application in diabetes treatment.

Career Highlights

Stefanie has built a reputable career, spending significant time at notable companies including Sanofi-Aventis Deutschland GmbH and Sanofi-Aventis. Her tenure at these organizations has allowed her to push the boundaries of pharmaceutical science and bring her innovative ideas to fruition.

Collaborations

Throughout her career, Stefanie has collaborated with distinguished professionals, including Wolfgang Wendler and Eugen Falk. These partnerships have been instrumental in enhancing her research endeavors and expanding the impact of her work within the industry.

Conclusion

Stefanie Keil's commitment to innovation and her extensive patent portfolio underscore her role as a prominent figure in the pharmaceutical landscape. Her inventions not only show potential in treating various health conditions but also pave the way for future research and development in the field, highlighting the vital intersection of science and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…